Hepatitis Vaccine (Engerix-B)

Hepatitis vaccine (Engerix-B): description of the drug

The hepatitis vaccine (Engerix-B) is one of the most effective and safe means for preventing hepatitis B. This vaccine was developed by GlaxoSmithKline and is marketed under the Engerix-B brand. The drug is produced in Russia and Belgium by SmithKline Beecham.

Hepatitis B is a viral liver disease that can lead to serious complications such as cirrhosis and cancer. The hepatitis B virus is transmitted through the blood and other fluids of a person infected with the virus. The hepatitis B vaccine helps protect the body against this virus.

The vaccine contains purified hepatitis B virus antigen, which does not contain live or weakened viruses. The vaccine stimulates the body's immune system to produce antibodies against the hepatitis B virus, which allows the body to more effectively fight the infection.

Hepatitis vaccine (Engerix-B) is available in several dosage forms: 20 mcg injection suspension 1 dose, 10 mcg injection suspension 1 dose, 20 mcg injection suspension 10 doses, 20 mcg injection suspension 5 doses, 10 injection suspension mcg 10 doses. The dosage of the vaccine depends on the age of the person who will be vaccinated.

Hepatitis Vaccine (Engerix-B) is recommended for the prevention of hepatitis B in all age groups, including newborns, children, adolescents and adults. The vaccine is injected into the muscle of the upper arm in two or three doses, depending on the person's age and health. The vaccine is generally well tolerated, but some people may experience mild side effects such as pain, redness and swelling at the site where the vaccine was given, fatigue and dizziness.

Hepatitis Vaccine (Engerix-B) is an effective and safe way to prevent hepatitis B. It is recommended that everyone who is at risk of contracting the virus be vaccinated, including health care workers, travelers, people who increase their risk of infection through daily activities, and those who lives or works in high-risk areas.